Clinical Care Options Hepatitis - HBV
- Management of Chronic Hepatitis B Virus Infection in Women of Reproductive Age
- HBV DNA Seroclearance Significantly Reduces Risk of HCC in Patients With High Baseline Viral Loads
- Prolonged Tenofovir-Based Antiviral Therapy Maintains HBV DNA Suppression in Patients With Chronic HBV, Normal ALT Levels, and High HBV DNA Levels
- Observed HCC Incidence Lower Than Predicted in Patients With Chronic Hepatitis B Receiving Tenofovir in Phase III Clinical Trials
- FISSION: Sofosbuvir/Ribavirin Noninferior to Peginterferon/Ribavirin for SVR12 in Treatment-Naive Patients With HCV Genotype 2/3
- More items from this source »
Clinical Care Options Hepatitis - HCV
- Additional Highlights of HCV Investigational Agents and HBV
- HCV Phase III Studies and Approved Agents
- MK-5172 Plus PegIFN/RBV Achieves 86% to 92% SVR24 Rates in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV
- Vaniprevir Plus PegIFN/RBV Significantly Increases SVR24 Rate vs PegIFN/RBV Retreatment in Cirrhotic, Genotype 1 HCV–Infected, Previous Nonresponders to PegIFN/RBV
- High SVR12 Rates With Short-Course (6 or 12 Weeks) of Ledipasvir and GS-9451 Plus PegIFN/RBV Quadruple Therapy in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV Infection and IL28B CC Genotype
- More items from this source »
Hepatitis B News Feed
- Accenture: Boom ahead for retail health clinics
- First Edition: June 13, 2013
- Video promotes awareness about safe injection practices
- Low levels of vitamin D associated with high levels of hepatitis B virus replication
- Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection
- More items from this source »
Medical News Today
- New Fluorescent Protein From Eel Revolutionizes Key Clinical Assay
- Researchers Make Discovery That May Lead To New Treatments For Jaundice
- Human Embryonic Stem Cells Can Be Differentiated Into Liver Progenitor Cells And Produce Mature Liver Cells
- Artificial Livers A Step Closer
- News From The Annals Of Internal Medicine: June 4, 2013
- More items from this source »
Science Daily
- Some omega-3 oils better than others for protection against liver disease
- Target 'super-spreaders' to stop hepatitis C
- Chronic hepatitis C: Interferon may be harmful in re-treatment
- Binge drinking can dramatically amplify damage to the liver
- Decline in available liver transplants expected
- More items from this source »